OncLive: Dr. Mesa on the potential utility of CAR T-cell therapy in MPNs

Ruben A. Mesa, MD, director of the Mays Cancer Center, discusses the potential utility of CAR T-​cell ​therapy in myeloproliferative neoplasms (MPNs) in this video.

Watch the interview.



Share This Article!
Article Categories: Cancer, In the News